Revenue
2021
2022
2023
2024
2025
Senti Biosciences Holdings, Inc. (SNTI)
Price$0.3316Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $22,000 | $0 | $2.0M | $3.3M | $2.3M |
| Research & development | $37.6M | $34.4M | $32.1M | $28.1M | $22.0M |
| Operating expenses | $68.8M | $61.0M | $95.3M | $66.4M | $43.2M |
| Operating income | −$68.8M | −$61.0M | −$92.7M | −$62.1M | −$40.4M |
| Operating margin | −312,631.82% | — | −4,687.92% | −1,889.35% | −1,765.43% |
| EBITDA | −$65.1M | −$57.2M | −$89.2M | −$60.7M | −$39.7M |
| EBITDA margin | −296,100.00% | — | −4,507.89% | −1,846.74% | −1,731.86% |
| Net income | −$61.4M | −$52.8M | −$71.1M | −$58.2M | −$55.3M |
| Net profit margin | −279,263.64% | — | −3,592.42% | −1,771.45% | −2,414.62% |
| Basic EPSper basic share | -$2.73 | -$12.03 | -$16.01 | -$22.30 | -$190.00 |
| Diluted EPSper diluted share | -$2.73 | -$12.03 | -$16.01 | -$22.30 | -$190.00 |
Owners
Reported shareholders
≈31.39%of listed shares
Celadon Partners SPV 249.78M shares · Mar 10, 2025
View holders
| Holder | % owned |
|---|---|
Celadon Partners SPV 24 | ≈31.39%9.78M shares |
Florence Anthony A. Jr. / SANDELL SCOTT D / New Enterprise Associates 15, L.P. / NEA Partners 15, L.P. / Makhzoumi Mohamad / BASKETT FOREST / NEA 15 GP, LLC | ≈12.12%3.78M shares |
Bayer US Holding LP / Bayer World Investments B.V. / BAYER AKTIENGESELLSCHAFT / BAYER HEALTHCARE LLC | ≈9.02%2.81M shares |
Nantahala Capital Management, LLC | 2.85%888K shares |
Lu Timothy K | ≈2.39%745.26K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 1.73%537.5K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.60%187.07K shares |
CITADEL ADVISORS LLC | 0.34%107.1K shares |
VANGUARD FIDUCIARY TRUST CO | 0.29%91.19K shares |
Rajangam Kanya | ≈0.24%74.84K shares |
JANE STREET GROUP, LLC | 0.17%52.53K shares |
Menlo Ventures Management, L.P. | 0.11%35.74K shares |
NORTHERN TRUST CORP | 0.10%32.15K shares |
XTX Topco Ltd | 0.08%23.61K shares |
Virtu Financial LLC | 0.07%22.8K shares |
UBS Group AG | 0.05%14.43K shares |
Tang Donald F | ≈0.03%10.37K shares |
Tower Research Capital LLC (TRC) | 0.02%7.34K shares |
ROYAL BANK OF CANADA | 0.01%4.02K shares |
BlackRock, Inc. | 0.01%4K shares |
Percentages use 31.14M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 6, 2025Form 4 | Lu Timothy KCEO | SellCommon Stock | 545 | $4.36 | $2.4K | 82.1K |
| Feb 6, 2025Form 4 | Rajangam KanyaPres. & Chief Med. & Dev. Off. | SellCommon Stock | 182 | $4.37 | $795.34 | 8.6K |
| Feb 4, 2025Form 4 | Lu Timothy KCEO | SellCommon Stock | 3.9K | $4.07 | $16.0K | 82.6K |
| Feb 4, 2025Form 4 | Rajangam KanyaPres. & Chief Med. & Dev. Off. | SellCommon Stock | 1.3K | $4.07 | $5.3K | 8.8K |
| Dec 9, 2024Form 4 | Bayer US Holding LP +3TenPercentOwner | BuyWarrant · derivative | 3.33M | — | — | 3.33M |